Topics

Videos

Founding Partner of Curatio Scientia speaks on her upcoming panel at Trade & Channel Strategies 2023. 

Trade & Channel Strategies 2023: An Interview with Cheryl Allen of Curatio Scientia

Lexicon Pharmaceuticals exec discusses upcoming Enable Holistic Hub and Provider Services panel. 

Trade & Channel Strategies 2023: An Interview with Paul Chen of Lexicon Pharmaceuticals

. He can be reached at nsaraceno@mjhlifesciences.com.

Articles

Panel uncovers ways to handle the increasing complexities and risks surrounding commercialization.

Trade & Channel Strategies 2023: Aligning Patient Access

To rebuild trust, companies should utilize a customer-centric approach, focusing on transparent and neutral content incorporating medical expertise and regularly seeking HCP feedback.

 Is Trust the Secret Ingredient for Digital Product Success?

Will result from Medicare reforms, despite increased drug uptake.

Continued Affordability Challenges in the Offing

David Laros is Vice President of Digital Strategy, Analytics and I﻿nsights at 

Methods that pharma companies can use to make the hub more personalized and experiential. 

Transforming the Patient Hub into a Hub of Patient Centricity

How to provide effective brand engagement in this rocky yet emerging landscape.

Navigating the Biosimilars Marketplace

Matt Wolf, president of biopharma services, Cencora, discusses the importance of partnership in helping to combat prescription drug abandonment and non-adherence.

An Outlook on Data-Powered Patient Support

Study emphasizes role in bridging research and development and commercial/marketing functions.

The Importance of the Medical Affairs Function in Pharmaceutical Companies

Digital twins allow the industry to integrate sustainable practices and supply chain efficiency solutions while ensuring patient safety.